Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2006) 11 OC16

ECE2006 Oral Communications Steroids and reproductive endocrinology (8 abstracts)

17β-estradiol regulates pituitary AnxA1 expression and externalization in vivo and in vitro

EL Davies 1 , HC Christian 1 , S Omer 1 , JC Buckingham 2 & JF Morris 1


1University of Oxford, England, United Kingdom; 2Imperial College, London, United Kingdom.


Annexin A1 (AnxA1) acts as a mediator of glucocorticoid (GC) actions in neuroendocrine systems. In the anterior pituitary Anx-1 is expressed mainly by folliculostellate (FS) cells and mediates the early-delayed feedback inhibition exerted by GCs on release of ACTH and other pituitary hormones. GC cause the externalization of AnxA1. The stress responsiveness of the female rat hypothalamo-pituitary-adrenal system varies with the estrous cycle, with increased CORT release in response to stress at proestrus (Viau 1991). Anterior pituitary Anx-l levels vary with the estrous cycle in the rat (with a peak at estrus) and are positively regulated by a physiological doses of 17β-estradiol (Davies 2005).

To determine whether increased AnxA1 leads to increased AnxA1 action, anterior pituitary tissue from ovariectomised (low AnxA1) and 17β-estradiol-treated (high AnxA1) animals was exposed to forskolin and/or dexamethasone in vitro. The addition of 0.1 μM dexamethasone caused a greater inhibition of the forskolin-stimulated ACTH release in tissue with a high AnxA1 content compared to tissue with a low AnxA1 content. The effect of 17β-estradiol on externalization of AnxA1 from FS cells was investigated using a mouse FS cell line, TtT/GF cells. TtT/GF cells externalize Anx1 in response to dexamethasone. 17β-estradiol pretreatment (180 nMol, 24 h) increased the quantity of Anx1 externalized in response to 0.1 μMol dexamethasone. This effect of 17β-estradiol was abolished by the estrogen receptor inhibitor ICI182,780. Consistent with this, immunofluorescence studies showed both ERα and ERβ localized to the nucleus of TtT/GF cells.

These data suggest that the variation in anterior pituitary AnxA1 with the estrous cycle is due to the action of estradiol acting through nuclear estrogen receptors. The estradiol-stimulated increase in total pituitary AnxA1 is associated with an increased GF effect. Estradiol potentiation of GC-stimulated externalization of AnxA1 would also increase the GC effect. Together, these data are consistent with the hypothesis that cyclic variation in anterior pituitary AnxA1 is a component of the change in stress responsiveness during the estrous cycle.

Volume 11

8th European Congress of Endocrinology incorporating the British Endocrine Societies

European Society of Endocrinology 
British Endocrine Societies 

Browse other volumes

Article tools

My recent searches

No recent searches.